Premaitha Health Plc (NIPT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Premaitha Health Plc (NIPT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9849
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that assists in estimating the risk of trisomy. The IONA test helps obviate the expensive, unnecessary and invasive diagnostic procedures such as amniocentesis. The company provides NIPT tests and services to clinical laboratories and healthcare professionals. The company offers its products directly to customers in Europe. It operates through a subsidiary, Yourgene Bioscience, in Taiwan, which provides it expanded market access in Asia. Premaitha Health is headquartered in Manchester, England, the UK.

Premaitha Health Plc (NIPT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Premaitha Health Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Premaitha Health Plc, Medical Devices Deals, 2012 to YTD 2018 9
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sagentia Enters into Agreement with Premaitha Health to Develop IONA Test for Prenatal Screening 11
Equity Offering 12
Premaitha Health Raises USD3.9 Million in Private Placement of Shares 12
Premaitha Health Raises USD12.5 Million in Private Placement of Shares 13
Premaitha Raises USD12 Million in Private Placement of Shares 14
Acquisition 15
Premaitha Health Acquires Yourgene Bioscience for USD9 Million 15
Premaitha Health Plc – Key Competitors 16
Premaitha Health Plc – Key Employees 17
Premaitha Health Plc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
May 15, 2018: Premaitha expands footprint with new laboratories in Kenya and India 19
Financial Announcements 20
Oct 01, 2018: Premaitha Health announce full year results to 31 March 2018 and half-year trading update 20
Sep 29, 2017: Premaitha Health: Full year results to 31 March 2017 and half-year trading update 28
Corporate Communications 30
Nov 02, 2018: Premaitha Health: Directorate change 30
Oct 03, 2018: Premaitha Health announce Directorate change 31
Sep 20, 2018: Premaitha Health: Senior commercial appointment and anticipated directorate change 32
Legal and Regulatory 33
Jan 24, 2018: UK High Court grants appeal against UK First Instance Judgment 33
Jul 03, 2017: Premaitha Health Litigation Update 34
Other Significant Developments 35
Jun 05, 2017: Premaitha Health: India Business Update 35
May 12, 2017: Premaitha Health: Update Re. Swiss Customer 36
Feb 07, 2017: Premaitha Health: Southern Europe Business Update 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Premaitha Health Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Premaitha Health Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Premaitha Health Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Premaitha Health Plc, Medical Devices Deals, 2012 to YTD 2018 9
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sagentia Enters into Agreement with Premaitha Health to Develop IONA Test for Prenatal Screening 11
Premaitha Health Raises USD3.9 Million in Private Placement of Shares 12
Premaitha Health Raises USD12.5 Million in Private Placement of Shares 13
Premaitha Raises USD12 Million in Private Placement of Shares 14
Premaitha Health Acquires Yourgene Bioscience for USD9 Million 15
Premaitha Health Plc, Key Competitors 16
Premaitha Health Plc, Key Employees 17
Premaitha Health Plc, Subsidiaries 18

List of Figures
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Premaitha Health Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Premaitha Health Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Premaitha Health Plc (NIPT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Century Casinos Inc:戦略・SWOT・企業財務分析
    Century Casinos Inc - Strategy, SWOT and Corporate Finance Report Summary Century Casinos Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tokio Marine Holdings, Inc.:企業の戦略・SWOT・財務情報
    Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Checkpoint Systems, Inc.:企業の戦略・SWOT・財務分析
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • China Cinda Asset Management Co Ltd:企業のM&A・事業提携・投資動向
    China Cinda Asset Management Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Cinda Asset Management Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • PT. Indonesia Power:企業の発電所・SWOT分析2018
    PT. Indonesia Power - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Xeikon N.V.:企業の戦略的SWOT分析
    Xeikon N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Grupa Azoty SA (ATT):企業の財務・戦略的SWOT分析
    Grupa Azoty SA (ATT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BBB Technologies Inc:企業の製品パイプライン分析2018
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company that develops medical devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. The company discovers and develops single-drop and mobile integrated diagnostic tool …
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • 1-800-FLOWERS.COM, Inc. (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM, Inc. (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Brookfield Office Properties Inc:企業のM&A・事業提携・投資動向
    Brookfield Office Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brookfield Office Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Mitsubishi Tanabe Pharma Corp (4508):製薬・医療:M&Aディール及び事業提携情報
    Summary Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, d …
  • Naver Corp (035420):企業の財務・戦略的SWOT分析
    Naver Corp (035420) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nikon Corporation:企業の戦略・SWOT・財務情報
    Nikon Corporation - Strategy, SWOT and Corporate Finance Report Summary Nikon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Teikoku Seiyaku Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Teikoku Seiyaku Co Ltd (Teikoku Seiyaku) is a medical device company that develops, manufactures and distributes medicated and medically related supplies. The company offers Chinese medicine, other medicinal products, quasi-drugs, cosmetics, hot sensation plaster, transdermal indomethacin me …
  • Coro Mining Corp:企業の戦略・SWOT・財務情報
    Coro Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Coro Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • AdvantEdge Healthcare Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • Bilim Pharmaceuticals:企業の戦略的SWOT分析
    Bilim Pharmaceuticals - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Ceylon Cold Stores PLC:企業の戦略・SWOT・財務情報
    Ceylon Cold Stores PLC - Strategy, SWOT and Corporate Finance Report Summary Ceylon Cold Stores PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mohawk Industries, Inc.:企業の戦略・SWOT・財務情報
    Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆